- ORAL CONTRACEPTION (Enrollment Closed)
- HPV TESTING(Enrollment Closed)
- ANEMIA
- INTRAUTERINE DEVICE (IUD) (Enrollment Closed)
- OVERACTIVE BLADDER(Enrollment Closed)
- CONTRACEPTION (TRANSDERMAL PATCH)(Enrollment Closed)
- ORAL CONTRACEPTION
- ORAL CONTRACEPTION
- ORAL CONTRACEPTION
- HOT FLASHES (Enrollment Begins March 2010)
- ENDOMETRIOSIS
ORAL CONTRACEPTION
Purpose
The primary objective of this study is to evaluate and compare bleeding patterns between three different dose extended cycle (91-day) oral contraceptive regimens.
Study Population
Females aged 18-45 years old that are not at risk for pregnancy and have an understanding and comprehension of the English language
Back to top
HPV TESTING
Purpose
The primary objective of this study is to establish the clinical sensitivity and specificity for the detection of cervical intraepithelial grade 3 (CIN3) or cancer by testing for certain types of HPV in DNA purified from liquid-based cervical cytology samples.
Study population
A sufficient number of women greater than or equal to 30 years of age undergoing routine cervical cancer screening (pap smear).
Back to top
ANEMIA
Purpose
The main objective of this study is to demonstrate the efficacy and safety of an investigational intravenous (IV) iron, ferric carboxymaltose, (FCM) compared to oral iron in subjects who have IDA and have been shown to have an unsatisfactory response to oral iron.
Study population
Male or female subjects at least 18 years of age with hemoglobin levels of 11 g/dL or less.
Back to top
INTRAUTERINE DEVICE (IUD)
Purpose
The primary objective of this study is to assess the safety, efficacy and pharmacokinetics of a new intrauterine contraceptive system administered for 3 years.
Study Population
Healthy 18 to 35 year-old nulliparous or parous females in need of contraception that are not at risk for pregnancy and have an understanding and comprehension of the English language
Back to top
OVERACTIVE BLADDER
Purpose
The purpose of this study is to evaluate the efficacy and safety of and Oxybutynin Vaginal Ring for overactive bladder symptoms in comparison to placebo as a study calibrator.
Study Population
Females 18 years of age or older, ambulatory, with a history and presentation consistent with pure or predominantly urge incontinence for greater than or equal to 6 months.
Back to top
CONTRACEPTION
Purpose
The primary objective of this study is to evaluate the contraceptive efficacy of the transdermal contraceptive patch.
Study Population
Females aged 18-35 with a history of regular cyclic menstrual periods.
Back to top
ORAL CONTRACEPTION
Purpose
Healthy females 18 to 50 years of age (smokers with a maximum age of 35 years) that are suffering from pelvic pain or headache while using a 21-day oral contraceptive and are willing to switch their current medication to the study medication.
Study Population
Females aged 18-50 with a history of regular cyclic menstrual periods.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Please fill out our questionnaire Click here(Internet Explorer only)
Back to top
ORAL CONTRACEPTION
Purpose
The primary objective is to investigate the bleeding pattern and cycle control parameters of the transdermal contraceptive patch in comparison to a combined oral contraceptive.
Study Population
Females aged 18-45 years requesting contraception, smokers with a maximum age of 35 at inclusion.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Please fill out our questionnaire Click here (Internet Explorer only)
Back to top
ORAL CONTRACEPTION
Purpose
The primary objective is to demonstrate teh efficacy and safety of a 91-day combination oral contraceptive regimen, utilizing ascending doses taken for 1 year in women desiring pregnancy prevention.
Study Population
Sexually active females who are at risk for pregnancy and 18-40 years of age.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Please fill out our questionnaire Click here (Internet Explorer only)
Back to top
HOT FLASHES
Purpose
The primary objective is to assess the safety and efficacy of a NON-HORMONAL treatment similar to an antidepressant as compared to placebo in reducing the average daily frequency and severity of hot flashes in postmenopausal women.
Study Population
Postmenopausal women 18 or more years of age who have been experiencing 7 or more moderate to severe hot flashes per day (or greater than 50 per week) accompanied by sweating during the previous 30 days or longer.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Please fill out our questionnaire Click here (Internet Explorer only)
Back to top
ENDOMETRIOSIS
Purpose
The purpose of this study is to determine whether a treatment for endometriosis in co-administration with an oral contraceptive, reduces pelvic pain and functional impairment due to pelvic pain when compared with placebo co-administered with the same oral contraceptive.
Study Population
Premenopausal females age 19 to 48 with laparoscopically confirmed endometriosis within the last 5 years experiencing pelvic pain.
Study medications and labs will be free. Financial compensation for time and travel will be provided.
Please fill out our questionnaire Click here (Internet Explorer only)
Back to top
